Filing Details

Accession Number:
0001179110-11-001590
Form Type:
4
Zero Holdings:
No
Publication Time:
2011-02-01 17:35:36
Reporting Period:
2011-01-31
Filing Date:
2011-02-01
Accepted Time:
2011-02-01 17:35:36
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1800 Abbott Laboratories ABT Pharmaceutical Preparations (2834) 360698440
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1200813 S Roy Roberts 317 Pine Ridge Drive
Bloomfield Hills MI 48304
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Shares Without Par Value Acquisiton 2011-01-31 5,616 $42.73 29,344 No 4 M Direct
Common Shares Without Par Value Acquisiton 2011-01-31 5,825 $41.20 35,169 No 4 M Direct
Common Shares Without Par Value Disposition 2011-01-31 8,441 $45.15 26,728 No 4 S Direct
Common Shares Without Par Value Disposition 2011-01-31 2,000 $45.15 24,728 No 4 S Direct
Common Shares Without Par Value Disposition 2011-01-31 400 $45.15 24,328 No 4 S Direct
Common Shares Without Par Value Disposition 2011-01-31 100 $45.15 24,228 No 4 S Direct
Common Shares Without Par Value Disposition 2011-01-31 100 $45.15 24,128 No 4 S Direct
Common Shares Without Par Value Disposition 2011-01-31 400 $45.15 23,728 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 M Direct
No 4 M Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
No 4 S Direct
Reported Derivative Transactions
Sec. Name Sec. Type Acquisiton - Disposition Date Amount Price Amount - 2 Price - 2
Common Shares Option (right to buy) Disposition 2011-01-31 5,616 $0.00 5,616 $42.73
Common Shares Option (right to buy) Disposition 2011-01-31 5,825 $0.00 5,825 $41.20
Remaning Holdings Exercise Date Expiration Date Equity Swap Involved Transaction Form Type Transaction Code Nature of Ownership
0 2001-04-27 2011-04-26 No 4 M Direct
0 2004-04-23 2014-04-22 No 4 M Direct
Footnotes
  1. Stock option granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, including a replacement option feature, in a transaction exepmt from Section 16 under Rule 16b-3.